| NCT Number | NCT07004296 |
| Lead Sponsor | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
| Conditions | Advanced Solid Tumors |
| Enrollment | 72 participants |
| Start Date | 2025-05-29 |
| Primary Completion | 2027-07-01 (estimated) |
| Study Completion | 2027-12-01 (estimated) |
| Updated on ClinicalTrials.gov | 2025-06-08 |